Schedule of Warrants Outstanding (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of Shares, Issued | 258,859 |
| Number of Shares, Warrants Outstanding, Balance | 7,683,891 |
| Common Stock Warrants [Member] | |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of Shares, Warrants Outstanding, Balance | 8,512,614 |
| Weighted Average Exercise Price, Warrants Outstanding, Balance per shares | $ / shares | $ 1.91 |
| Number of Shares, Issued | |
| Number of Shares, Exercised | (817,392) |
| Weighted Average Exercise Price, Exercised | $ / shares | $ 1.34 |
| Number of Shares, Expired | (11,331) |
| Weighted Average Exercise Price, Expired | $ / shares | $ 37.00 |
| Number of Shares, Warrants Outstanding, Balance | 7,683,891 |
| Weighted Average Exercise Price, Warrants Outstanding, Balance per share | $ / shares | $ 1.92 |
| Weighted Average Remaining Contractual Life (in Years) | 3 years 10 months 20 days |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option exercised in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option forfeited or expired in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for Non-option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|